RhumbLine Advisers’s Oak Street Health, Inc. OSH Stock Holding History

RhumbLine Advisers’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-124,936	Closed	-$4.83M	–	4415
2023 Q1	$4.83M	Sell	124,936 -1,922	-2%	-$62K	0.01%	1335
2022 Q4	$2.73M	Buy	126,858 +5,845	+5%	+$122K	﹤0.01%	1621
2022 Q3	$2.97M	Buy	121,013 +12,394	+11%	+$328K	﹤0.01%	1547
2022 Q2	$1.79M	Buy	108,619 +23,832	+28%	+$463K	﹤0.01%	1823
2022 Q1	$2.28M	Sell	84,787 -7,952	-9%	-$168K	﹤0.01%	1745
2021 Q4	$3.07M	Buy	92,739 +1,287	+1%	+$48.7K	﹤0.01%	1639
2021 Q3	$3.89M	Sell	91,452 -2,135	-2%	-$115K	0.01%	1504
2021 Q2	$5.48M	Buy	93,587 +13,863	+17%	+$825K	0.01%	1377
2021 Q1	$4.33M	Buy	79,724 +62,608	+366%	+$3.48M	0.01%	1485
2020 Q4	$1.05M	Buy	17,116 +6,013	+54%	+$315K	﹤0.01%	2111
2020 Q3	$593K	Buy	+11,103	New	+$497K	﹤0.01%	2209

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

RhumbLine Advisers's OSH Position: Q2 2023 in Review

RhumbLine Advisers sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 124,936 shares — an estimated $4.83M sold.

RhumbLine Advisers first reported a position in OSH in Q3 2020 and held it in 11 quarters. The position peaked at $5.48M in Q2 2021. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

RhumbLine Advisers reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
RhumbLine Advisers sold 124,936 Oak Street Health, Inc. shares in Q2 2023, an estimated $4.83M.
RhumbLine Advisers first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 11 quarters.
RhumbLine Advisers's Oak Street Health, Inc. position peaked at $5.48M in Q2 2021.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.